申请人:Zimmerman Craig
公开号:US20090175794A1
公开(公告)日:2009-07-09
Novel radiopharmaceuticals that are useful in diagnostic imaging and therapeutic treatment of disease characterized by over expression of CA-IX comprise a complex that contains a sulfonamide moiety which is capable of binding the active catalytic site of CA-IX, and a radionuclide adapted for radioimaging and/or radiotherapy:
具有在诊断成像和治疗过度表达CA-IX疾病中有用的新型放射性药物,包括一种含有磺胺基团的复合物,该基团能够结合CA-IX的活性催化位点,以及适用于放射成像和/或放射治疗的放射性核素: